News Health & Medicine

How the weight loss drug tirzepatide is also helping heart failure patients

Two clinical trials add evidence for the medication's benefits

An injector of the weight loss drug tirzepatide, brand name zepbound, floating on a blue background.

Tirzepatide, the main ingredient in the weight loss drug Zepbound (shown here), may also offer benefits to patients who have a common heart failure condition.

Eli Lilly and Company

By Meghan Rosen

CHICAGO — ­New clinical trial results on the diabetes and obesity drug tirzepatide have doctors buzzing about its potential to treat heart failure, keep weight off and prevent type 2 diabetes.